Z-1107-2021 Class II Terminated

Recalled by Phadia US Inc — Portage, MI

FDA device recall Z-1107-2021 was initiated by Phadia US Inc on Dec 14, 2020 and is designated Class II. Reason for recall: Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results). The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 365 kits US.

Recall details

Product Type
Devices
Report Date
Feb 17, 2021
Initiation Date
Dec 14, 2020
Termination Date
Aug 4, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
365 kits US

Product description

EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE). Material Number: 14-5500-01

Reason for recall

Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).

Distribution pattern

US Nationwide distribution.

Code information

Carrier Lot Number: BFA3Y; Kit Lot Number: 0142; (UDI): 07333066019406

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1107-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1107-2021. Report a data issue: hello@regdatalab.com.